Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.

Blood
Kiarash KojouriJ N George

Abstract

Splenectomy has been a standard treatment for adult patients with idiopathic thrombocytopenic purpura (ITP) for more than 50 years. However, the durability of responses, the ability to predict who will respond, and the frequency of surgical complications with splenectomy all remain uncertain. To better interpret current knowledge we systematically identified and reviewed all 135 case series, 1966 to 2004, that described 15 or more consecutive patients who had splenectomy for ITP and that had data for 1 of these 3 outcomes. Complete response was defined as a normal platelet count following splenectomy and for the duration of follow-up with no additional treatment. Forty-seven case series reported complete response in 1731 (66%) of 2623 adult patients with follow-up for 1 to 153 months; complete response rates did not correlate with duration of follow-up (r = -0.103, P = .49). None of 12 preoperative characteristics that have been reported consistently predicted response to splenectomy. Mortality was 1.0% (48 of 4955 patients) with laparotomy and 0.2% (3 of 1301 patients) with laparoscopy. Complication rates were 12.9% (318 of 2465) with laparotomy and 9.6% (88 of 921 patients) with laparoscopic splenectomy. Although the risk of ...Continue Reading

References

Jul 16, 1977·Lancet·C D Robinette, J F Fraumeni
Sep 1, 1979·The Southeast Asian Journal of Tropical Medicine and Public Health·M J Larrieu
Jan 11, 1975·British Medical Journal·A I Macpherson, J Richmond
Nov 1, 1992·Surgical Endoscopy·B Delaitre, B Maignien
Sep 1, 1992·World Journal of Surgery·P ChirlettiV Stipa
Jun 1, 1989·The Australian and New Zealand Journal of Surgery·M E PitcherJ R Mackay
Feb 1, 1989·The Australian and New Zealand Journal of Surgery·J H Shaw, M A Clark
Jun 1, 1988·Postgraduate Medical Journal·W WanachiwanawinS Vatanavicharn
Jul 1, 1988·The American Journal of the Medical Sciences·T H GuthrieL M Prisant
May 1, 1987·The British Journal of Surgery·A A DawsonD J King
Jun 1, 1985·World Journal of Surgery·S I Schwartz
Sep 1, 1985·Journal of Clinical Pathology·M M HayesD M Dent
Mar 1, 1974·The Japanese Journal of Surgery·Y OgawaA Iwaki
Sep 1, 1973·Archives of Internal Medicine·R M JiJiC L Spurling
Mar 1, 1968·The American Journal of Digestive Diseases·W Silber
Jun 1, 1970·American Journal of Surgery·R P Hodam
Aug 1, 1970·Journal of Chronic Diseases·E OrringerL Rosenbach
Sep 1, 1967·Archives of Surgery·R C WildeW M Cooper
Jan 1, 1984·Scandinavian Journal of Haematology·G J den OttolanderA Brand
Aug 1, 1984·Southern Medical Journal·M V Rocco, R S Stein
Jan 1, 1983·Scandinavian Journal of Haematology·W KayserG Mueller-Eckhardt
May 1, 1984·The American Journal of Medicine·W G HockingR W Busuttil
Jul 1, 1984·Annals of Surgery·G MusserR W Busuttil
Nov 1, 1980·The American Journal of Medicine·V J PicozziW P Creger
May 1, 1981·Archives of Surgery·S J MintzR C Richards
Feb 1, 1995·Archives of Disease in Childhood·M M Reid
May 1, 1995·The American Journal of Medicine·R StasiS Amadori
Jun 1, 1995·British Journal of Haematology·F HernándezM Perella
Feb 1, 1995·Annals of Internal Medicine·R F Schilling

❮ Previous
Next ❯

Citations

Mar 22, 2006·Annals of Hematology·Francisco Javier PeñalverUNKNOWN Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP
May 18, 2006·Annals of Hematology·Panagiotis A KonstantinopoulosBruce J Dezube
May 16, 2007·Annals of Hematology·R SimanekI Pabinger
Jun 8, 2010·Annals of Hematology·Francisco Javier PeñalverUNKNOWN Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA
Oct 6, 2010·Annals of Hematology·Mehdi KhellafBertrand Godeau
Jul 26, 2011·Annals of Hematology·Bob OlssonHans Wadenvik
Jul 1, 2006·Wiener klinische Wochenschrift·Klaus LechnerIngrid Pabinger
Mar 4, 2008·Journal of Thrombosis and Thrombolysis·Semir PasaOrhan Ayyildiz
Feb 14, 2008·Clinical Reviews in Allergy & Immunology·Laurent Sailler
Jan 1, 2013·International Journal of Hematology·Tomonori NakazatoYoshinobu Aisa
May 25, 2013·International Journal of Hematology·Hirokazu Kashiwagi, Yoshiaki Tomiyama
Mar 1, 2009·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Vrushali DabakPhilip Kuriakose
Oct 1, 2009·La Revue de médecine interne·Jean-François Viallard
Sep 9, 2008·Nature Medicine·Andrew Wei, Shaun P Jackson
Aug 26, 2011·The New England Journal of Medicine·Paul Imbach, Mark Crowther
Nov 12, 2010·The New England Journal of Medicine·James N George
Nov 12, 2010·The New England Journal of Medicine·David J KuterDietmar P Berger
Dec 13, 2012·Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a·Rosario VecchioEmma Cacciola
Oct 16, 2007·Current Opinion in Hematology·Bertrand GodeauJames Bussel
Sep 28, 2007·Current Opinion in Hematology·Nichola CooperRoberto Stasi
Jun 26, 2009·Current Opinion in Hematology·Adrian Newland
Nov 26, 2009·Journal of Gastroenterology and Hepatology·Morimasa TomikawaYoshihiko Maehara
Dec 18, 2012·The Journal of Clinical Investigation·Matthieu MahévasClaude-Agnès Reynaud
Jan 18, 2011·Hematology·Adam Cuker, Douglas B Cines
Dec 10, 2013·Hematology·Cindy E Neunert
Mar 23, 2012·BMC Blood Disorders·T Michelle BrownChris L Pashos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.